[
    [
        {
            "time": "2019-01-02",
            "original_text": "又 是 尾 盘 发 力 ！ 北 上 资 金 逆 势 净 买 入 近 1 3 亿 ， 重 点 买 了 这 类 标 的 ！",
            "features": {
                "keywords": [
                    "尾盘",
                    "北上资金",
                    "逆势净买入"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "又 是 尾 盘 发 力 ！ 北 上 资 金 逆 势 净 买 入 近 1 3 亿 ， 重 点 买 了 这 类 标 的 ！",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-06-15",
            "original_text": "2 0 1 9 全 球 制 药 企 业 5 0 强 榜 单 出 炉 ！ 国 内 2 家 药 企 上 榜",
            "features": {
                "keywords": [
                    "全球制药企业50强",
                    "国内药企上榜"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "2 0 1 9 全 球 制 药 企 业 5 0 强 榜 单 出 炉 ！ 国 内 2 家 药 企 上 榜",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "2019-07-20",
            "original_text": "实 控 人 签 订 虚 假 合 同 套 取 3 2 9 4 . 8 7 万 元 ？ 贵 州 益 佰 制 药 收 警 示 函  其 他 违 规 处 罚",
            "features": {
                "keywords": [
                    "实际控制人",
                    "虚假合同",
                    "贵州益佰制药",
                    "警示函"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "实 控 人 签 订 虚 假 合 同 套 取 3 2 9 4 . 8 7 万 元 ？ 贵 州 益 佰 制 药 收 警 示 函  其 他 违 规 处 罚",
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-08-10",
            "original_text": "国 内 P A R P 抑 制 剂 研 发 大 热  9 款 候 选 药 已 获 批 临 床",
            "features": {
                "keywords": [
                    "PARP抑制剂",
                    "研发",
                    "临床试验"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "国 内 P A R P 抑 制 剂 研 发 大 热  9 款 候 选 药 已 获 批 临 床",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-09-25",
            "original_text": "新 鲜 出 炉 ！ 全 球 T O P 5 0 制 药 企 业 榜 单 公 布 ！ 2 家 中 国 药 企 首 次 上 榜 ！",
            "features": {
                "keywords": [
                    "全球TOP50制药企业",
                    "中国药企首次上榜"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "新 鲜 出 炉 ！ 全 球 T O P 5 0 制 药 企 业 榜 单 公 布 ！ 2 家 中 国 药 企 首 次 上 榜 ！",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]